Post-approval studies (Phase 4)Enrolling By InvitationNCT05777993
What this trial is testing
Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study
Who this might be right for
Pyruvate Kinase DeficiencyAnemia, HemolyticSickle Cell Disease+1 more
Agios Pharmaceuticals, Inc. 59